We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+15.63%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$925M
AUM Growth
+$121M
Cap. Flow
-$1.06M
Cap. Flow %
-0.11%
Top 10 Hldgs %
22.31%
Holding
255
New
7
Increased
77
Reduced
98
Closed
5

Top Buys

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$6.4M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.73M
3
CVS icon
CVS Health
CVS
+$2.43M
4
MSFT icon
Microsoft
MSFT
+$2.14M
5
V icon
Visa
V
+$1.6M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.75M
2
CELG
Celgene Corp
CELG
+$5.4M
3
AL
Air Lease Corp
AL
+$2.84M
4
AMT icon
American Tower
AMT
+$1.93M
5
KMI icon
Kinder Morgan
KMI
+$1.36M

Sector Composition

Rank Sector Weight
1 Healthcare 16.89%
2 Technology 16.36%
3 Industrials 11.15%
4 Consumer Staples 8.91%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UGI icon
201
UGI
UGI
$7.33B
$416K 0.05%
7,500
– –
VYM icon
202
Vanguard High Dividend Yield ETF
VYM
$82.8B
$414K 0.04%
4,830
– –
IGM icon
203
iShares Expanded Tech Sector ETF
IGM
$10.7B
$412K 0.04%
12,000
– –
SWKS icon
204
Skyworks Solutions
SWKS
$10.6B
$412K 0.04%
5,000
– –
CDK
205
DELISTED
CDK Global, Inc.
CDK
$411K 0.04%
6,986
– –
UNH icon
206
UnitedHealth
UNH
$370B
$409K 0.04%
1,656
– –
UPS icon
207
United Parcel Service
UPS
$88.9B
$403K 0.04%
3,610
– –
VOO icon
208
Vanguard S&P 500 ETF
VOO
$1.01T
$401K 0.04%
1,544
+77
+5% +$19.2K
UL icon
209
Unilever
UL
$136B
$388K 0.04%
5,978
-155
-3% -$9.44K
AVY icon
210
Avery Dennison
AVY
$13.4B
$385K 0.04%
3,410
– –
TXN icon
211
Texas Instruments
TXN
$261B
$385K 0.04%
3,625
– –
SYY icon
212
Sysco
SYY
$40.3B
$384K 0.04%
5,750
-100
-2% -$6.5K
TJX icon
213
TJX Companies
TJX
$178B
$383K 0.04%
7,190
– –
COHR
214
DELISTED
Coherent Inc
COHR
$383K 0.04%
2,702
– –
CRSP icon
215
CRISPR Therapeutics
CRSP
$5.17B
$371K 0.04%
10,400
– –
CI icon
216
Cigna
CI
$74.6B
$346K 0.04%
2,151
+227
+12% +$41.5K
MA icon
217
Mastercard
MA
$493B
$345K 0.04%
1,464
– –
FRST icon
218
Primis Financial Corp
FRST
$404M
$335K 0.04%
22,900
– –
VT icon
219
Vanguard Total World Stock ETF
VT
$79.8B
$329K 0.04%
4,500
– –
BKNG icon
220
Booking.com
BKNG
$161B
$309K 0.03%
4,425
+225
+5% +$16.1K
CATC
221
DELISTED
CAMBRIDGE BANCORP
CATC
$305K 0.03%
3,679
– –
FIS icon
222
Fidelity National Information Services
FIS
$22.1B
$303K 0.03%
2,675
– –
SBUX icon
223
Starbucks
SBUX
$120B
$303K 0.03%
4,076
– –
GPN icon
224
Global Payments
GPN
$22.8B
$299K 0.03%
2,190
-235
-10% -$28.5K
DOV icon
225
Dover
DOV
$28.4B
$295K 0.03%
3,141
– –
6 7 8
9
10

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return

Boston Family Office's Q1 2019 Portfolio in Review

As of Q1 2019, Boston Family Office held 255 positions worth $925M, up 15% from $804M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4.7%. Boston Family Office opened 7 new positions and exited 5, leaving the 255-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

  • Boston Family Office's largest Q1 2019 buy was Enanta Pharmaceuticals: 2,750 shares worth $263K.
  • Boston Family Office added most to Air Products & Chemicals in Q1 2019, an estimated $6.4M increase.
  • Boston Family Office's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $5.4M.
  • Boston Family Office fully exited Linde in Q1 2019, selling an estimated $7.75M.
  • Boston Family Office's ten largest holdings make up 22% of its $925M portfolio in Q1 2019.
  • Boston Family Office opened 7 new positions and closed 5 in Q1 2019.
  • Boston Family Office's portfolio value rose 15% quarter-over-quarter to $925M.

Based on Boston Family Office's 13F filing for Q1 2019, filed 9 May 2019.